Clorox Co’s filing revealed that its Director Breber Pierre R acquired Company’s shares for reported $0.55 million on May 07 ’25. In the deal valued at $136.57 per share,4,000 shares were bought. As a result of this transaction, Breber Pierre R now holds 4,000 shares worth roughly $0.54 million.
Then, Marriner Kirsten sold 7,494 shares, generating $1,136,251 in total proceeds. Upon selling the shares at $151.62, the EVP – Chief People Officer now owns 27,038 shares.
Before that, Marriner Kirsten sold 733 shares. Clorox Co shares valued at $109,950 were divested by the EVP – Chief People Officer at a price of $150.00 per share. As a result of the transaction, Marriner Kirsten now holds 26,305 shares, worth roughly $3.55 million.
Wells Fargo upgraded its Clorox Co [CLX] rating to an Equal weight from a an Underweight in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who increased its forecast for the stock in early November from “a Sell” to “a Hold”. Jefferies also remained covering CLX and has increased its forecast on October 01, 2024 with a “Buy” recommendation from previously “Hold” rating. TD Cowen started covering the stock on July 23, 2024. It rated CLX as “a Sell”.
Price Performance Review of CLX
On Monday, Clorox Co [NYSE:CLX] saw its stock fall -1.05% to $134.84. Over the last five days, the stock has lost -2.33%. Clorox Co shares have fallen nearly -16.98% since the year began. Nevertheless, the stocks have fallen -2.58% over the past one year. While a 52-week high of $171.37 was reached on 01/27/25, a 52-week low of $127.60 was recorded on 05/06/25.
How much short interest is there in Clorox Co?
A steep rise in short interest was recorded in Clorox Co stocks on 2025-04-30, growing by 0.64 million shares to a total of 4.17 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 3.53 million shares. There was a rise of 15.32%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 24, 2024 when Exane BNP Paribas began covering the stock and recommended ‘”an Underperform”‘ rating along with a $130 price target.
